Abstract
Objective
We evaluated the effect of estrogen administration on endothelin (ET) secretion in primary amenorrheic (PA) adolescent girls.
Methods
Fifteen PA adolescents (ten hypergonadotropic, group A; five hypogonadotropic, group B) were treated with estrogen and progestogen tablets. A control group often healthy adolescents (group C) was included in the study. The ET 1–21, FSH, and LH plasma levels were tested bejore treatment (PrT) and immediately after the last estrogen tablet but bejore the progestogen administration (PoT).
Results
A statistically significant difference (P <.01) in ET 1–21 plasma values was found between PrT (9.66 ± 0.80 pmol/L) and PoT (7.56 ± 0.89 pmol/L) levels in group A cases. A similar reduction (P <.05) was recorded between PrT (8.06 ± 0.46 pmol/L) and PoT (5.59 ± 0.53 pmol/L) ET 1–21 plasma levels in group B cases. Endothelin 1–21 plasma PrT values were higher in both group A and B cases in comparison with controls (6.66 ± 0.44 pmol/L; P < .01, P < .1, respectively).
Conclusion
Estrogens administered to PA adolescents reduce ET 1–21 plasma levels in both hyper- and hypogonadotropism.
Similar content being viewed by others
References
Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411–5.
Kamada S, Kubota T, Taguchi M, Aso T. High levels of immunoreactive endothelin-1 in human follicular fluids. Hum Reprod 1993;8:674–7.
Iwai M, Hasegavva M, Taii S, et al. Endothelin inhibits luteinization of cultured porcine granulosa cells. Endocrinology 1991;129:1909–14.
Baxter RC, Martin JL. Binding proteins for the insulin-like growth factors: Structure, regulation and function. Prog Growth Factor Res 1989;1:49–68.
Tedeschi C, Hazum E, Kokia E, Ricciarelli E, Adashi EY, Payne DW. Endothelin-1 as a luteinization inhibitor: Inhibition of rat granulosa cell progesterone accumulation via selective modulation of key steroidogenic steps affecting both progesterone formation and degradation. Endocrinology 1992;131:2476–81.
Moretto M, Lopez FJ, Negro-Vilar A. Endothelin-3 stimulates luteinizing hormone-releasing hormone (LHRH) secretion from LHRH neurons by a prostaglandin-dependent mechanism. Endocrinology 1993;132:789–94.
Stojilkovic SS, Merelli F, Iida T, Krsmanovic LZ, Catt KJ. Endothelin stimulation of cytosolic calcium and gonadotropin secretion in anterior pituitary cells. Science 1990;248:1663–6.
Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17 β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 1992;263:H271–5.
Collins P, Rosano GM, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Cardiovascular protection by oestrogen—a calcium antagonist effect? Lancet 1993;341:1264–5.
Nayler WG. The endothelins. Berlin: Spnnger Verlag, 1990;116–47.
Hirata Y, Yoshimi H, Takata S, et al. Cellular mechanism of action by a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. Biochem Biophys Res Commun 1988;154:868–75.
Marsden PA, Danthuluri NR, Brenner BM, Ballermann BJ, Brock TA. Endothelin action on vascular smooth muscle involves inositol trisphosphate and calcium mobilization. Biochem Biophys Res Commun 1989;158:86–93.
Stice SI, Ford SP, Rosazza JP, Van-Orden DE. Role of 4-hy-droxylated estradiol in reducing Ca2+ uptake of uterine smooth muscle cells through potential sensitive channels. Biol Reprod 1987;37:361–8.
Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17 β-oestradiol in vitro. Br J Pharmacol 1991;104:1033–7.
Jiang C, Poole-Wilson PA, Sarrel PM, Mochizuki S, Collins P, MacLeod KT. Effect of 17-P-oestradiol on contraction, Ca2+ current and intracellular free Ca2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992;106:739–45.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Creatsas, G.C., Malamitsi-Puchner, A.B., Hassan, E.A. et al. Endothelin Plasma Levels in Primary Amenorrheic Adolescents Before and After Estrogen Treatment. Reprod. Sci. 3, 350–353 (1996). https://doi.org/10.1016/S1071-5576(96)00034-2
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1071-5576(96)00034-2